Milan Petrovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Milan Petrovic has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Drago Jelovac
Clinic for Maxillofacial Surgery, School of Dental Medicine, University of Belgrade, Serbia
4 shared publications - Estevam Augusto Bonfante
Department of Prosthodontics and Periodontology Bauru School of Dentistry, University of São Paulo Bauru São Paulo Brazil
2 shared publications - Jelena Milasin
Department of Human Genetics, School of Dental Medicine, University of Belgrade, Belgrade, Serbia
2 shared publications - Maja Milosevic Markovic
School of Dental Medicine, University of Belgrade, 11000 Belgrade, Serbia
2 shared publications - Milutin Micic
Center for Bone Biology, Institute for Anatomy, Faculty of Medicine, University of Belgrade, Serbia
2 shared publications - Adam Stebel
Department of Maxillofacial Surgery, F. D. Roosevelt University Hospital, 975 17 Banska Bystrica, Slovakia
1 shared publication
Latest Publications
- Open Access
Cytotoxic Effects of Thymus serpyllum L. and Mentha × piperita L. Essential Oils on Basal Cell Carcinoma—An In Vitro Study
This study investigated the potential of Thymus serpyllum L. and Mentha × piperita L. essential oils (EOs), known for their bioactive properties, as adjunctive treatments targeting Basal cell carcinoma cancer stem cells (BCC CSCs). Primary cultures were established from ten BCC tumor samples and their distant resection margins as controls. The chemical composition of the EOs was analyzed by gas chromatography–mass spectroscopy (GC-MS) and attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR). The biological effects were evaluated via colony and spheroid formation, scratch assays, MTT and neutral red cytotoxicity assays, and qRT-PCR for Hh (SHH, PTCH1, SMO, and GLI1) and Notch (Notch1 and JAG1) gene expression. GC analysis identified thymol, p-cymene, and linalool as the main components of the EO of T. serpyllum L., and menthone and menthol in the EO of M. × piperita L. IC50 values were 262 µg/mL for T. serpyllum L. and 556 µg/mL for M. × piperita L. and were applied in all experiments. Both EOs significantly reduced CSC clonogenicity and migration (p < 0.05). The EO of T. serpyllum L. downregulated SMO and GLI1, while the EO of M. × piperita L. upregulated PTCH1, Notch1, and JAG1 (p < 0.05). These findings suggest that both EOs exhibit anticancer effects in BCC CSCs by modulating key oncogenic pathways, supporting their potential in BCC therapy.
Open AccessCytotoxic Effects of Thymus serpyllum L. and Mentha × piperita L. Essential Oils on Basal Cell Carcinoma—An In Vitro Study
This study investigated the potential of Thymus serpyllum L. and Mentha × piperita L. essential oils (EOs), known for their bioactive properties, as adjunctive treatments targeting Basal cell carcinoma cancer stem cells (BCC CSCs). Primary cultures were established from ten BCC tumor samples and their distant resection margins as controls. The chemical composition of the EOs was analyzed by gas chromatography–mass spectroscopy (GC-MS) and attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR). The biological effects were evaluated via colony and spheroid formation, scratch assays, MTT and neutral red cytotoxicity assays, and qRT-PCR for Hh (SHH, PTCH1, SMO, and GLI1) and Notch (Notch1 and JAG1) gene expression. GC analysis identified thymol, p-cymene, and linalool as the main components of the EO of T. serpyllum L., and menthone and menthol in the EO of M. × piperita L. IC50 values were 262 µg/mL for T. serpyllum L. and 556 µg/mL for M. × piperita L. and were applied in all experiments. Both EOs significantly reduced CSC clonogenicity and migration (p < 0.05). The EO of T. serpyllum L. downregulated SMO and GLI1, while the EO of M. × piperita L. upregulated PTCH1, Notch1, and JAG1 (p < 0.05). These findings suggest that both EOs exhibit anticancer effects in BCC CSCs by modulating key oncogenic pathways, supporting their potential in BCC therapy.
- Open Access
- 2 May 2025
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 53 (8) , 1113-1122
Multicenter 14-year follow-up of fibula vascular grafts of mandibles and maxillae restored with short and extra-short implants
- 2 May 2025
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 53 (8) , 1113-1122
Open AccessMulticenter 14-year follow-up of fibula vascular grafts of mandibles and maxillae restored with short and extra-short implants
- Open Access
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES)
- No. Oral prese,p. 110
Patients with oral cancer in the healthcare system of Serbia
Background: Patients with oral cancer have a significantly impaired quality of life and in Serbia they are among the ten most common tumours in male population. Methods and Objectives: The aim of this study was to determine the recognition of this population group in the health care system in Serbia. During the June 2024 a review and analysis of relevant health policies, strategies, programs and other documents related to health in the Republic of Serbia, was undertaken. Results: According to the Law on Health Insurance, these patients have the right to full coverage of costs for examinations and treatment of teeth and mouth diseases as part of the preoperative and postoperative treatment, as well as rehabilitation with post-resection prostheses. The measures and activities of currently active programs for prevention and early detection of certain types of tumours and the National Program of Preventive Dental Health Care (2009) do not recognize this population group as a priority. Given that a third of these tumours are caused by Human Papillomavirus (HPV) infection, the availability of this vaccine in our country is significant. Since 2006 the HPV vaccine has been available in Serbia, since 2019 it is on the list of recommended vaccines by the National Immunization Program, and since 2022 it is available through health insurance fund. Policies and strategies that target commercial determinants, such as alcohol and tobacco, are receiving increasing attention at the national level, in recent years. Conclusions: In the observed Serbian population, despite a good dental health care coverage there are plenty of space to improve actions and measures to prevent oral cancer.
- 1 January 2024
- Published by Centre for Evaluation in Education and Science (CEON/CEES)
- No. Oral prese,p. 110
Open AccessPatients with oral cancer in the healthcare system of Serbia
Background: Patients with oral cancer have a significantly impaired quality of life and in Serbia they are among the ten most common tumours in male population. Methods and Objectives: The aim of this study was to determine the recognition of this population group in the health care system in Serbia. During the June 2024 a review and analysis of relevant health policies, strategies, programs and other documents related to health in the Republic of Serbia, was undertaken. Results: According to the Law on Health Insurance, these patients have the right to full coverage of costs for examinations and treatment of teeth and mouth diseases as part of the preoperative and postoperative treatment, as well as rehabilitation with post-resection prostheses. The measures and activities of currently active programs for prevention and early detection of certain types of tumours and the National Program of Preventive Dental Health Care (2009) do not recognize this population group as a priority. Given that a third of these tumours are caused by Human Papillomavirus (HPV) infection, the availability of this vaccine in our country is significant. Since 2006 the HPV vaccine has been available in Serbia, since 2019 it is on the list of recommended vaccines by the National Immunization Program, and since 2022 it is available through health insurance fund. Policies and strategies that target commercial determinants, such as alcohol and tobacco, are receiving increasing attention at the national level, in recent years. Conclusions: In the observed Serbian population, despite a good dental health care coverage there are plenty of space to improve actions and measures to prevent oral cancer.
- Open Access
- 7 September 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (18) , 6727
Melatonin Action in Type 2 Diabetic Parotid Gland and Dental Pulp: In Vitro and Bioinformatic Findings
Type 2 diabetes mellitus (T2DM) is associated with functional deterioration of the salivary gland and dental pulp, related to oxidative stress. The aim was to integrate experimental and bioinformatic findings to analyze the cellular mechanism of melatonin (MEL) action in the human parotid gland and dental pulp in diabetes. Human parotid gland tissue was obtained from 16 non-diabetic and 16 diabetic participants, as well as human dental pulp from 15 non-diabetic and 15 diabetic participants. In human non-diabetic and diabetic parotid gland cells (hPGCs) as well as in dental pulp cells (hDPCs), cultured in hyper- and normoglycemic conditions, glial cell line-derived neurotrophic factor (GDNF), MEL, inducible nitric oxide synthase (iNOS) protein expression, and superoxide dismutase (SOD) activity were measured by enzyme-linked immunosorbent assay (ELISA) and spectrophotometrically. Bioinformatic analysis was performed using ShinyGO (v.0.75) application. Diabetic participants had increased GDNF and decreased MEL in parotid (p < 0.01) and dental pulp (p < 0.05) tissues, associated with increased iNOS and SOD activity. Normoglycemic hDPCs and non-diabetic hPGCs treated with 0.1 mM MEL had increased GDNF (p < 0.05), while hyperglycemic hDPCs treated with 1 mM MEL showed a decrease in up-regulated GDNF (p < 0.05). Enrichment analyses showed interference with stress and ATF/CREB signaling. MEL induced the stress-protective mechanism in hyperglycemic hDPCs and diabetic hPGCs, suggesting MEL could be beneficial for diabetes-associated disturbances in oral tissues.
- 7 September 2023
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (18) , 6727
Open AccessMelatonin Action in Type 2 Diabetic Parotid Gland and Dental Pulp: In Vitro and Bioinformatic Findings
Type 2 diabetes mellitus (T2DM) is associated with functional deterioration of the salivary gland and dental pulp, related to oxidative stress. The aim was to integrate experimental and bioinformatic findings to analyze the cellular mechanism of melatonin (MEL) action in the human parotid gland and dental pulp in diabetes. Human parotid gland tissue was obtained from 16 non-diabetic and 16 diabetic participants, as well as human dental pulp from 15 non-diabetic and 15 diabetic participants. In human non-diabetic and diabetic parotid gland cells (hPGCs) as well as in dental pulp cells (hDPCs), cultured in hyper- and normoglycemic conditions, glial cell line-derived neurotrophic factor (GDNF), MEL, inducible nitric oxide synthase (iNOS) protein expression, and superoxide dismutase (SOD) activity were measured by enzyme-linked immunosorbent assay (ELISA) and spectrophotometrically. Bioinformatic analysis was performed using ShinyGO (v.0.75) application. Diabetic participants had increased GDNF and decreased MEL in parotid (p < 0.01) and dental pulp (p < 0.05) tissues, associated with increased iNOS and SOD activity. Normoglycemic hDPCs and non-diabetic hPGCs treated with 0.1 mM MEL had increased GDNF (p < 0.05), while hyperglycemic hDPCs treated with 1 mM MEL showed a decrease in up-regulated GDNF (p < 0.05). Enrichment analyses showed interference with stress and ATF/CREB signaling. MEL induced the stress-protective mechanism in hyperglycemic hDPCs and diabetic hPGCs, suggesting MEL could be beneficial for diabetes-associated disturbances in oral tissues.
- Open Access
- 1 January 2012
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Srce i krvni sudovi
- Vol. 31 (4) , 166-173
Clinical application of cardiopulmonary exercise testing in current cardiology practice and special patient subsets
Cardiopulmonary exercise test is reproducible, simple and accurate non-invasive method that provides additional useful information to standard exercise testing as an integral part of a growing number of recommendations and guidelines. Aerobic functional capacity can be estimated from expiratory gass analysis, in patients with unexplained exertional dyspnea, and in determination of diagnosis and prognosis for various groups of patients with heart, lung and muscle diseases. The choice of parameters depends on the type of disease we studied from stratification of heart failure to prescription of rehabilitation and participation in competitive sports.
- 1 January 2012
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Srce i krvni sudovi
- Vol. 31 (4) , 166-173
Open AccessClinical application of cardiopulmonary exercise testing in current cardiology practice and special patient subsets
Cardiopulmonary exercise test is reproducible, simple and accurate non-invasive method that provides additional useful information to standard exercise testing as an integral part of a growing number of recommendations and guidelines. Aerobic functional capacity can be estimated from expiratory gass analysis, in patients with unexplained exertional dyspnea, and in determination of diagnosis and prognosis for various groups of patients with heart, lung and muscle diseases. The choice of parameters depends on the type of disease we studied from stratification of heart failure to prescription of rehabilitation and participation in competitive sports.
- 1 January 2009
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 15 (32) , 3409
Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma
- 1 January 2009
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 15 (32) , 3409
Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma